https://orcid.org/0000-0001-8405-8637
References
- Wadhwa R , AggarwalT , MalylaVet al. Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease. J. Cell. Physiol.234(10), 16703–16723 (2019).
- Mehta M , Deeksha , TewariDet al. Oligonucleotide therapy: an emerging focus area for drug delivery in chronic inflammatory respiratory diseases. Chem. Biol. Interact.308, 206–215 (2019).
- Zhang Y , ChanJW , MorettiA , UhrichKE. Designing polymers with sugar-based advantages for bioactive delivery applications. J. Control. Release219, 355–368 (2015).
- Kavitha A , ParambathA. Polyacrylamide and related polymers. In: Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol.Elsevier Inc, Cambridge, UK, 229–253 (2018).
- Li X , ChenG. Glycopolymer-based nanoparticles: synthesis and application. Polym. Chem.6(9), 1417–1430 (2015).
- Horoiwa TA , DeOliveira AM , MigottoA , CerizeNNP. Process evaluation of sugar-based polymeric colloidal nanocarrier formation. Mater. Res.22(2), e20180074 (2019).
- Liu Z , JiaoY , WangY , ZhouC , ZhangZ. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev.60(15), 1650–1662 (2008).
- Eroglu M , ToksoyOner E , CanseverMutlu E , SennarogluBostan M. Sugar based biopolymers in nanomedicine; new emerging era for cancer imaging and therapy. Curr. Top. Med. Chem.17(13), 1507–1520 (2017).
- Kaur G , NarangRK , RathG , GoyalAK. Advances in pulmonary delivery of nanoparticles. Artif. Cells Blood Substit. Immobil. Biotechnol.40(1–2), 75–96 (2012).
- Dua K , WadhwaR , SinghviGet al. The potential of siRNA based drug delivery in respiratory disorders: recent advances and progress. Drug Dev. Res.80(6), 714–730 (2019).
- Chellappan DK , YeeLW , XuanKYet al. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases. Drug Dev. Res.81(4), 419–436 (2020).
- Pandolfi L , FrangipaneV , BoccaCet al. Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells. Molecules24(18), 3291 (2019).
- Lee R , ChoiYJ , JeongMSet al. Hyaluronic acid-decorated glycol chitosan nanoparticles for pH-sensitive controlled release of doxorubicin and celecoxib in nonsmall cell lung cancer. Bioconjug. Chem.31(3), 923–932 (2020).
- Menon JU , KuriakoseA , IyerRet al. Dual-drug containing core-shell nanoparticles for lung cancer therapy. Sci. Rep.7(1), 1–13 (2017).
- Hoang B , ErnstingMJ , RoyA , MurakamiM , UndzysE , LiSD. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism. Biomaterials59, 66–76 (2015).
- Paul P , SenguptaS , MukherjeeB , ShawTK , GaonkarRH , DebnathMC. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice. Nanomedicine13(5), 501–520 (2018).
- Oyarzun-Ampuero FA , BreaJ , LozaMI , TorresD , AlonsoMJ. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int. J. Pharm.381(2), 122–129 (2009).
- Campbell R , ChongG , HawkesE. Novel indications for Bruton's tyrosine kinase inhibitors, beyond hematological malignancies. J. Clin. Med.7(4), 62 (2018).
- Zhao L , TangB , TangPet al. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles for ibrutinib delivery: a potential nanoformulation of novel kinase inhibitor. J. Pharm. Sci.109(2), 1136–1144 (2020).
- Alhajj N , ZakariaZ , NaharudinI , AhsanF , LiW , WongTW. Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalation. Asian J. Pharm. Sci.15(3), 374–384 (2019).